Advert - Novartis – Case AUTH/3655/6/22

• Date posted
  18 October 2023
• Sanction
  Advertisement,
• Case number/s
  AUTH/3655/6/22 - Anonymous Health Professional v Novartis

For referring to Mayzent initiation in patients with a history of myocardial infarction and heart failure without making apparent the absolute contra-indication in patients with a history of myocardial infarction or heart failure in the previous 6 months, except on a separate webpage and within the prescribing information which, in the Panel’s view, was insufficient to negate this immediate misleading impression, Novartis was ruled in breach of the following Clauses of the 2021 Code:

Clause 2           - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 5.1        - Failing to maintain high standards

Clause 6.1        - Misleading impression provided

Clause 6.2        - Misleading impression incapable of substantiation